Cytochrome P450, Family 2, Subfamily R, Polypeptide 1 (CYP2R1) Peptide
CYP2R1
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all CYP2R1 products
- CYP2R1 (Cytochrome P450, Family 2, Subfamily R, Polypeptide 1 (CYP2R1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- FKQLITNAVS NITNLIIFGE RFTYEDTDFQ HMIELFSENV ELAASASVFL
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CYP2 R1 antibody,
Alternative Names: CYP2R1 control peptide, CYP2R1 antibody Blocking Peptide, Anti-CYP2R1 Blocking Peptide, cytochrome P450, family 2, subfamily R, polypeptide 1 Blocking Peptide, MGC4663 Blocking Peptide, CYP2R1, CYPR1-2, CYPR1 2, CYPR1-2 Blocking Peptide, CYPR1 2 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- CYP2R1 (Cytochrome P450, Family 2, Subfamily R, Polypeptide 1 (CYP2R1))
- Background
- This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This enzyme is a microsomal vitamin D hydroxylase that converts vitamin D into the active ligand for the vitamin D receptor. A mutation in this gene has been associated with selective 25-hydroxyvitamin D deficiency.
- Molecular Weight
- 57 kDa
-
You are here:
